Letter: a 5-year long-term follow-up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis-Reference-Cited by-同舟云学术

Letter: a 5-year long-term follow-up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis

Published:2019-12-18 Issue:1 Volume:51 Page:194-195
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ebel Friederike¹,Deterding Katja²,Port Kerstin¹,Schlevogt Bernhard³,Manns Michael P.¹⁴⁵^ORCID,Maasoumy Benjamin¹,Cornberg Markus¹^ORCID,Wedemeyer Heiner²⁴⁵^ORCID

Affiliation:

1. Department of Gastroenterology, Hepatology and Endocrinology; Hannover Medical School; Hannover Germany

2. Department of Gastroenterology & Hepatology; Essen University Hospital; Essen Germany

3. Department of Transplantation Medicine; University of Muenster; Muenster Germany

4. Integrated Research and Treatment Center Transplantation (IFB-Tx); Hannover Germany

5. German Center for Infection Research (DZIF); Hannover-Braunschweig Germany

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15597/fullpdf

Reference6 articles.

1. Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs;Nahon;Gastroenterology,2018

2. Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia;Ji;Aliment Pharmacol Ther,2018

3. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study;Singer;Aliment Pharmacol Ther,2018

4. HCC immune surveillance and antiviral therapy of hepatitis C virus infection;Owusu Sekyere;Liver Cancer,2019

5. The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis;Mecci;Aliment Pharmacol Ther,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature;Hepatology;2024-02-20

2. Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?;Transplantation;2022-05-12

3. HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis;Hepatology;2022-02-07

4. Declining numbers of hepatitis-C-virus-associated liver transplantations in Germany;Deutsches Ärzteblatt international;2021-11-19

5. Postoperative direct‐acting antiviral treatment after liver resection in patients with hepatitis C virus‐related hepatocellular carcinoma;Hepatology Research;2021-09-21